In this issue:
James Paulson on Functional Genomics (
2008 Barnett Lectures)
Biogenerics 2008 Conference
Saul Kurlat Joins Strategic Advisory Board
Dan Levangie Joins Strategic Advisory Board
Barnett Institute Establishes Science Advisory Board
Peter Barrett Appointed Adjunct Professor
The 2007 Hoehn Lectures, on "Biogenerics"
Rob Garnick appointed Adjunct Professor
Graham Jones appointed Associate Director
New Project to Study Role of Homocysteine in Autism
Barry Karger to Receive Csaba Horvath Medal
Ben Cravatt Presents Activity-Based Protein Profiling (Barnett
Lecture)
Barnett Institute Awards Ceremony
Barnett Institute to host Biogenerics Conference
Alliance of Glycobiologists for Detection of Cancer and Cancer
Risk
Institute Retreat Symposium
Alumni spotlights: Beverly Brenner and Emanuel Carrilho
Prof. Karger to Receive Bergman Medal
Institute Receives Canary Foundation Award
Prof. Karger Elected to Hungarian Academy of Sciences
James
Paulson presents "Functional Glycomics"
(The 2008 Barnett Lectures)
"Life is sugar-coded": glycans decorate the surface
of cells with unique molecular signatures that play critical
roles in their communications. The information in this
sugar "code" is read by glycan binding proteins; the
paradigms of this interaction are central to innate and adaptive
immunity, and evident in the aberrant phenotypes of cancer cells.
The emerging revelations of the biological pathways mediated
by glycans is driving the rapid development of analytical and
informatic tools for glycan analysis. (photo
gallery) (10/2/08)
Biogenerics2008, a conference on the scientific and
regulatory issues surrounding the introduction of protein pharmaceuticals
made by generic manufacturers, was hosted by the Barnett Institute
on March 2-4 at the Boston Copley Marriott.
The conference brought together decision-making representatives
from the regulatory agencies of the US, Europe, Japan and Canada,
with senior management of both the biotechnology and generics
industries, and leading academic laboratories.
Panel discussions followed sessions on Analytical, Manufacturing,
Immunogenicity, and Regulatory issues.
(program)

From left: Charles DiLiberti (Barr Laboratories),
Mary Alice Hefford (Health Canada), Amy Rosenberg (US FDA),
Robert Garnick (Genentech), David Drake (Novartis), Alison Lawton
(Genzyme).
Barnett Institute Establishes Science Advisory Board
The Advisory Board decided to next meet in two sessions: Strategic
and Scientific. The scientific board will concentrate on the
technical and research opportunities for Institute development.
The new members of the Science Advisory Board are: Dr. Steven
Carr of the Broad Institute, Prof. Cathy Costello
of Boston University School of Medicine; Prof. John Essigmann
of MIT; Dr. James Green, Senior Vice President at Biogen
Idec; Dr. Josh LaBaer of Harvard Medical School, and
Dr. Dennis Sgroi of Harvard Medical School. We are honored
that such an accomplished group of individuals has agreed to
serve on the Board. (roster)

Dr. Karger with new Advisory Board members Laurie Werner
and Eliot Barnett,
children of Louis and Madlyn Barnett.
Saul Kurlat Joins Advisory Board
Saul Kurlat has accepted an invitation to join the Barnett
Institute Advisory Board. Saul is an alumnus of Northeastern
University, receiving an MS degree in Engineering Management
in 1962. Currently, he serves on the Scientific Advisory
Board of Northeastern’s Center for Sub-Surface Imaging and Sensing
Systems, is a Visiting Distinguished Professor of Engineering
Leadership in the College of Engineering, and was asked by President
Aoun to advise him how the life sciences could be strengthened
at Northeastern .. (more)
(1/29/2008)
Dan Levangie Joins Advisory Board
Dan Levangie, Director of Hologic, as well as Ev3, Minneapolis,
MN, and Dune Medical, Ltd, Caesaria, IL, .has agreed to join
the Advisory Board of the Barnett Institute. Dan received
his B.S. degree in Pharmacy from Northeastern University in
1973; he rose to Regional Sales Manager of the Pharmaceutical
Products at Abbott Labs before joining Cytyc Corporation in
1992. Recently, as President, Cytyc Surgical Products
Division, Dan supported a very successful collaboration with
the Barnett Institute which discovered diagnostic protein biomarkers
to augment the cytological assay of the Pap smear.
Dan's broad and extensive experience in the health/diagnostic
industry will be a wonderful addition to the Board. (more)
(1/11/2008).
Peter Barrett Appointed Adjunct Professor of Barnett Institute
Dr. Barrett is currently a Senior Partner for Life Sciences
at Atlas Ventures, and Vice Chairman of Barnett Institute Advisory
Board. Previously, Peter was co-founder with Craig Venter
of Celera ... (more).
The 2007 Hoehn Lectures, on "Biogenerics: The
Issues and the Science" were held on November 27'th.
Dr. Rob Garnick, Senior Vice President, Genentech, presented
The Biogeneric Dilemma - A Global Perspective.
Neil Kelleher, Associate Professor of Chemistry at the University
of Illinois, spoke on The Evolving Role of Tandem Mass Spectrometry
in Contemporary Protein Science.
(more on Garnick
Kelleher
Hoehn Photo
Gallery).

Dr. Karger, Neil Kelleher, Rob Garnick, and Dieter Hoehn.
(photo by Craig Bailey).
Rob Garnick appointed Adjunct Professor of Barnett Institute
(12/6/2007)
Dr. Garnick is Senior Vice President of Regulatory,
Quality and Compliance at Genentech. He is a loyal alumnus
who serves on the Advisory Board of the Barnett Institute, and
has especially distinguished himself in bringing 18 protein
therapeutic products to market. (more)
Graham Jones appointed Associate Director of Barnett Institute
(12/5/2007) Previously
a Faculty Fellow, Prof. Jones will play an expanded role
assisting the Institute in our outreach programs to industry
and the hospitals, as we grow in size and reputation.
Graham is also Chairman of the Department of Chemistry and Chemical
Biology and a Special Assistant to the Provost. (more)
New Project to Study Role of Homocysteine in Autism.
Professor Zhaohui Sunny Zhou, with Richard Deth of Pharmacology,
has received a grant from the Autism Research Institute to investigate
the role of homocysteine thiolactone in autism. This interdisciplinary
team is implementing proteomic techniques to detect and characterize
proteins that are modified by homocysteine thiolactone, and
investigate their role in autism. (more)
(7 November, 2007)
Barry Karger to Receive Csaba Horvath Medal
(29 October, 2007) The
Board of Directors of the Connecticut Separation Science Council
(CSSC) and the Horvath Laboratory of Bioseparation Sciences,
at the Leopold-Franzens University Innsbruck, Austria, announced
today that Dr. Karger has been nominated as the next recipient
of the Csaba Horváth Medal Award of the Connecticut Separation
Science Council. He will receive this award during the 8th Csaba
Horvath Medal Award Symposium to be held on April 14 - 15, 2008
in Innsbruck, Austria.
Ben
Cravatt Presents Activity-Based Protein Profiling
(The Twenty-Sixth Annual Barnett Lectureship). Dr. Cravatt
has pioneered the field of Activity-Based Protein Profiling
(ABPP) which uses active-site-directed chemical probes to determine
the functional states of large numbers of enzymes in the whole
proteome, together with analogous metabolomic methods for discovery
metabolite profiling (DMP). The lectures were followed
by a reception and dinner in honor of Dr. Cravatt and his accomplishments.
More Information
Photo Gallery
Barnett Institute Awards Ceremony
Students
and research faculty were honored for major achievements over
the recent year. Fiscal Officer Bill O'Neill was recognized
for exceptional diligence. Ruthann Stiles of the Provost's
office received the External Service Award. The ceremonies
were opened this year with presentations from distinguished
alumni Marek Minarik and Emanuel Carrilho.
Full story with pictures.
photo gallery
Barnett Institute to host Biogenerics
Conference
By the year 2010, $20 billion worth of protein pharmaceuticals
will be off patent and in a market open to generic manufacturers.
Subtle changes, such as in glycosylation or formulation, may
show dramatic effects, or no effect, on efficacy and safety.
The scientific and regulatory issues surrounding biogenerics
(biosimilars or follow-on biologicals) are some of the most
difficult since biotechnology was established. Biogenerics
2008 is bringing the highest levels in industry and regulatory
leadership into an open discussion and wide-ranging debate.
Biogenerics 2008 site
Alliance of Glycobiologists for Detection
of Cancer and Cancer Risk.
Prof. Hancock is co-chair of the coordination unit of the alliance.
This is an exciting time for glycomics, as a wide array of breakthrough
technologies and methods are emerging. The Alliance is
an NCI-funded program to accelerate communication, collaboration
and application of these new tools. The Barnett Institute
has contributed MLAC for isolating glycoproteins and ERPA for
comprehensive characterization of the glycans in large proteins.
(more
information) (CRISP)
Institute
Retreat Symposium
The Institute retreat this year emphasized and strengthened
our interactions with affiliated and collaborating laboratories.
In addition to the Barnett Institute Fellows, the day-long event
included presentations by colleagues Hanno Steen of
Children's Hospital, Joseph Zaia of Boston University
Medical Center, Rohin Mhatre, Director of Bioprocess
Development at Biogen-Idec, and Igor Kaltashov
from UMASS Amherst.
Beverly
Brenner returns to visit; Emanuel
Carrilho on sabbatical in Boston
(see Alumni News)

Beverly Brenner at luncheon with Jana Volf
and Tomas Rejtar |

Emanuel Carrilho with Elma and Lorena |
Prof. Karger to Receive Bergman Medal
Barry Karger, Director of the Barnett Institute, has been selected
to receive the 2008
Torbern Bergman Medal from the Analytical Division of the
Swedish Chemical Society. This is one of the most prestigious
international awards in the field of analytical chemistry and
is offered only every other year. Barry will receive the medal
at a special symposium in his honor in Gothenburg, Sweden next
June. This award brings more acclaim to the Barnett Institute
and continues our growth as a major intellectual research center.
Institute Receives Canary Foundation Award
In June 2007, the experimental bioinformatics group at the Barnett
Institute received a "Bioinformatics Platform Dissemination"
Award from the Canary Foundation to adopt a Computational Proteomics
Analysis System (CPAS). (more)
Prof Karger Elected to Hungarian Academy
of Sciences
Prof. Karger was recently elected an Honorary Member of the
Hungarian Academy of Sciences. While membership in the
Hungarian Academy is generally restricted to Hungarian citizens,
in special cases scholars or scientists active in a foreign
country may be elected to become honorary members of the academy
if they pursue their field on an internationally recognized
level, and their achievements are worthy of the special esteem
of Hungarian scientific life.